Skip Nav Destination
Issue Archive
January 1 2000
Table of Contents
EDITORIAL
PLENARY PAPER
Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study
Stig Lenhoff,Martin Hjorth,Erik Holmberg,Ingemar Turesson,Jan Westin,Johan Lanng Nielsen,Finn Wislöff,Lorentz Brinch,Kristina Carlson,Margaretha Carlsson,Inger-Marie Dahl,Peter Gimsing,Erik Hippe,Hans E. Johnsen,Jon Lamvik,Eva Löfvenberg,Ingerid Nesthus,Stig Rödjer,for the Nordic Myeloma Study Group
The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype
Belinda K. Singleton,Carole A. Green,Neil D. Avent,Peter G. Martin,Elizabeth Smart,Abigail Daka,Edwin G. Narter-Olaga,Linda M. Hawthorne,Geoff Daniels
REVIEW ARTICLES
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells
Thomas B. Campbell,Anne Sevin,Robert W. Coombs,Gregory C. Peterson,Mary Rosandich,Daniel R. Kuritzkes,Jeannette Mladenovic,Alan Landay,Roberta Wong,Daniel Ambruso,Steve Miles,Roger J. Pomerantz,Robert T. Schooley,the Adult AIDS Clinical Trials Group 285 Study Team
Molecular heterogeneity in complete cytogenetic responders after interferon-α therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission
Andreas Hochhaus,Andreas Reiter,Susanne Saußele, Anja Reichert,Michael Emig,Jaspal Kaeda,Beate Schultheis,Ute Berger,Patricia C. A. Shepherd,Norman C. Allan,Rüdiger Hehlmann,John M. Goldman,Nicholas C. P. Cross,for the German CML Study Group and the UK MRC CML Study Group
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome: Presented in part at the meeting of the American Society of Hematology, San Diego, CA, December 1997.
Martin S. Tallman,Janet W. Andersen,Charles A. Schiffer,Frederick R. Appelbaum,James H. Feusner,Angela Ogden,Lois Shepherd,Jacob M. Rowe,Christopher François,Richard S. Larson,Peter H. Wiernik
A prospective study of residual-disease monitoring of theALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia
Giuseppe Cimino,Loredana Elia,Maria Cristina Rapanotti,Teresa Sprovieri,Marco Mancini,Antonio Cuneo,Cristina Mecucci,Giuseppe Fioritoni,Mario Carotenuto,Enrica Morra,Vincenzo Liso,Luciana Annino,Giuseppe Saglio,Giulio De Rossi,Robin Foà,Franco Mandelli
HEMATOPOIESIS
Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins
Pankaj Gupta,Theodore R. Oegema, Jr,Joseph J. Brazil,Arkaduisz Z. Dudek,Arne Slungaard,Catherine M. Verfaillie
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor
Marc Jacquemin,Abdellah Benhida,Kathelijne Peerlinck,Benoı̂t Desqueper,Luc Vander Elst,Renaud Lavend'homme,Roseline d'Oiron,Rainer Schwaab,Marleen Bakkus,Kris Thielemans,Jean-Guy Gilles,Jos Vermylen,Jean-Marie Saint-Remy
Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation
Mariagrazia De Luca,David A. Facey,Emmanuel J. Favaloro,Mark S. Hertzberg,James C. Whisstock,Tracy McNally,Robert K. Andrews,Michael C. Berndt
Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide
Hideo Kimura,Alessandro Weisz,Yukiko Kurashima,Kouichi Hashimoto,Tsutomu Ogura,Fulvio D'Acquisto,Raffaelo Addeo,Masatoshi Makuuchi,Hiroyasu Esumi
IMMUNOBIOLOGY
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)
Mette D. Hazenberg,James W. T. Cohen Stuart,Sigrid A. Otto,Jan C. C. Borleffs,Charles A. B. Boucher,Rob J. de Boer,Frank Miedema,Dörte Hamann
NEOPLASIA
PHAGOCYTES
RED CELLS
TRANSFUSION MEDICINE
TRANSPLANTATION
BRIEF REPORTS
-
Cover Image
Cover Image
- PDF Icon Table of ContentsTable of Contents
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals